Grants and Contributions:
Title:
Design and Testing of Assays to Enable Rapid Prototyping
Agreement Number:
975372
Agreement Value:
$74,700.00
Agreement Date:
Sep 1, 2021 - Mar 31, 2022
Description:
Develop a rapid assay platform to support rapid testing and screening of a vast array of formulations to support our goal of increasing the stability of antibody based therapeutics.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burlington, Ontario, CA L7L 4X5
Reference Number:
172-2021-2022-Q2-975372
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
756228474
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
Amendment Date
Jan 13, 2022
Recipient's Legal Name:
Elarex Inc.
Federal Riding Name:
Burlington
Federal Riding Number:
35015
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: